Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China flag China · Delayed Price · Currency is CNY
271.48
+2.10 (0.78%)
At close: Mar 20, 2026

SHA:688506 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-3,220403.961,005154.22
Short-Term Investments
-2,533---
Cash & Short-Term Investments
6,1575,753403.961,005154.22
Cash Growth
7.02%1324.16%-59.79%551.49%-36.99%
Accounts Receivable
-138.71137.85267.92134.95
Other Receivables
-34.333.95.142.95
Receivables
-173.05141.75273.06137.9
Inventory
-162.19140.91101.3382.33
Other Current Assets
-218.8789.247.2249.36
Total Current Assets
-6,307775.821,426423.81
Property, Plant & Equipment
-573.09534.79420.26404.98
Other Intangible Assets
-26.682829.5331.16
Long-Term Deferred Tax Assets
-179.276.1883.2365.8
Long-Term Deferred Charges
-18.41.821.791.16
Other Long-Term Assets
-32.798.530.2824.54
Total Assets
-7,1371,4251,991951.46
Accounts Payable
-219.25160.17128.8545.96
Accrued Expenses
-437.25257.88244.81139.81
Short-Term Debt
-595.5275.12155.13161.23
Current Portion of Long-Term Debt
-235.28174.3730.470.02
Current Portion of Leases
-20.1946.1368.8224.23
Current Income Taxes Payable
-14.130.014.961.54
Current Unearned Revenue
-356.138.6717.4210.78
Other Current Liabilities
-102.21131.4886.7487.75
Total Current Liabilities
-1,9801,054737.2471.32
Long-Term Debt
-1,189183.92239.9650
Long-Term Leases
-28.138.6552.9551.42
Long-Term Unearned Revenue
-42.2715.6313.2931.04
Long-Term Deferred Tax Liabilities
-1.94-0.08-
Other Long-Term Liabilities
-9.7311.1914.0515.81
Total Liabilities
-3,2511,2731,058619.61
Common Stock
-401401401360.9
Additional Paid-In Capital
-885.84858.69858.5514.17
Retained Earnings
-2,599-1,109-328.45-45.98
Comprehensive Income & Other
-0.531.132.792.76
Total Common Equity
7,1713,886151.87933.89331.85
Shareholders' Equity
7,1713,886151.87933.89331.85
Total Liabilities & Equity
-7,1371,4251,991951.46
Total Debt
3,7712,069688.19547.33286.91
Net Cash (Debt)
2,3863,685-284.23457.41-132.69
Net Cash Growth
-35.24%----
Net Cash Per Share
5.779.19-0.711.26-0.37
Filing Date Shares Outstanding
412.87401401401360.9
Total Common Shares Outstanding
412.87401401401360.9
Working Capital
-4,327-278.01689.14-47.51
Book Value Per Share
17.379.690.382.330.92
Tangible Book Value
7,1423,859123.88904.36300.69
Tangible Book Value Per Share
17.309.620.312.260.83
Buildings
-325.3304.56302.23300.82
Machinery
-640.12554.25439.83419.75
Construction In Progress
-35.5181.3767.2118.18
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.